Welcome to our dedicated page for Novanta news (Ticker: NOVT), a resource for investors and traders seeking the latest updates and insights on Novanta stock.
Novanta Inc. reports developments as a Nasdaq-listed supplier of core technology solutions for medical, life science and advanced industrial original equipment manufacturers. Its updates center on precision medicine, precision manufacturing, robotics and automation, and advanced surgery, including laser beam steering and scanning, laser sources, robotic and precision motion technologies, medical insufflators, endoscopic pumps and integrated operating room technologies.
Company news commonly covers quarterly earnings releases, conference calls, investor presentations, OEM design wins, product and technology collaborations, and capital actions tied to balance-sheet and securities structure. Recent themes include motion control and sensing technologies for robotics certification environments and tangible equity unit financing.
Novanta reported strong financial results for Q2 2021, achieving GAAP revenue of $167.5 million, up 15.8% from Q2 2020. Bookings soared 77% year-over-year, highlighting robust customer demand. Operating income rose to $16.0 million, while adjusted diluted EPS increased to $0.62 from $0.48. The company expects continued growth, projecting Q3 revenue between $165 million and $170 million and full-year revenue of $660 million to $670 million. Future growth is anticipated from pending acquisitions of ATI and SEM.
Novanta Inc. (NASDAQ: NOVT) has agreed to acquire ATI Industrial Automation for $172 million in cash, with additional contingent payments based on ATI's 2021 performance. ATI specializes in intelligent end-of-arm technology solutions for robotics in industrial and medical applications, expecting over $70 million in revenue for 2021. The acquisition aims to enhance Novanta's position in robotics, particularly in electric vehicles and medical sectors, creating a $250 million Precision Motion Segment. The deal is expected to close in Q3 2021 and to be accretive to Novanta's earnings.
Novanta Inc. (Nasdaq: NOVT) will announce its second quarter 2021 results on August 10, 2021, followed by a conference call at 10:00 a.m. ET. Participants can join by dialing (888) 346-3959 or via a live webcast. The audio replay will be available approximately three hours post-call until October 4, 2021. Novanta specializes in providing advanced technology solutions for healthcare and industrial OEMs, focusing on photonics, vision, and precision motion.
Novanta Inc. (NASDAQ: NOVT) has announced an agreement to acquire Schneider Electric Motion USA for $115 million in cash, with an expected close in the third quarter of 2021. SEM specializes in motion control components for automation, enhancing Novanta's capabilities in robotics and medical technology. This acquisition aligns with Novanta's strategy to expand its precision motion control portfolio and increase exposure to Life Sciences and Medical markets. The deal is projected to be accretive to Novanta's free cash flow and non-GAAP earnings per share.
Novanta Inc. (Nasdaq:NOVT), a trusted partner to medical and advanced technology manufacturers, announced that CFO Robert Buckley will present at the 21st Annual CJS Securities New Ideas Summer Conference on July 13, 2021. The conference will be held virtually.
About Novanta: Novanta is a leading global supplier of core technology solutions, specializing in photonics, vision, and precision motion. The company provides engineered components and sub-systems designed for extreme precision and performance, catering to the demands of OEMs in medical and industrial sectors.
Novanta Inc. (Nasdaq: NOVT) announced that CEO Matthijs Glastra and CFO Robert Buckley will present at Baird's 2021 Global Consumer, Technology & Services Conference on June 8, 2021. This virtual event showcases Novanta's role as a key technology partner for medical and advanced technology OEMs, emphasizing its expertise in photonics, vision, and precision motion. The company's innovative professionals are committed to delivering high-performance solutions tailored to customer needs, positioning Novanta as a leader in core technology solutions.
Summary not available.
Novanta Inc. (Nasdaq: NOVT), a technology partner for medical and advanced technology equipment manufacturers, announced that CEO Matthijs Glastra and CFO Robert Buckley will present at William Blair's 41st Annual Growth Stock Conference on May 26, 2021. This virtual event highlights Novanta's role as a leading global supplier of technology solutions, focusing on photonics, vision, and precision motion for OEMs. The company's commitment to innovation and customer success drives its growth. More details are available at www.novanta.com.
Novanta reported Q1 2021 revenues of $162.6 million, a 4.6% increase year-over-year. Operating income declined to $11.1 million from $13.3 million, with net income at $11.3 million compared to $11.9 million in Q1 2020. Adjusted diluted EPS rose to $0.58 from $0.51. The company noted a 28% increase in bookings sequentially and 25% year-over-year, driven by strong demand in advanced industrial sectors. Guidance for Q2 forecasts revenue of $162 million to $165 million and for the full year expects revenue between $645 million to $655 million.
Novanta Inc. (Nasdaq: NOVT) will announce its Q1 2021 results on May 11, 2021, at 10:00 a.m. ET. Investors can join the conference call by dialing (888) 346-3959 or via a live webcast on the Company’s website. A replay of the call will be available approximately three hours post-call until July 5, 2021. Novanta is a global leader in core technology solutions, specializing in photonics, vision, and precision motion, aimed at enhancing the performance of healthcare and industrial OEMs.